This edition announces that CMS will 1) return to certain pre-COVID-19 policies in long-term care and other facilities and 2) host a stakeholder call about coverage policies for monoclonal antibodies that target amyloid for the treatment of Alzheimer’s disease.
CMS has developed an FAQ document based on questions received from providers regarding the coronavirus (COVID-19). Note: The first link was revised March 10, 2020.
First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.